Skip to main content
. 2016 Apr 9;4:28–36. doi: 10.1016/j.dadm.2016.03.004

Table 1.

Baseline characteristics of individuals with MCI, interviewed and not interviewed at the follow-up

Baseline characteristics All individuals with MCI (n = 655) Interviewed, (n = 362) Not interviewed, (n = 293) P value
Gender
 Women, n (%) 366 (55.9) 206 (56.9) 160 (54.6) .556
Age, mean ± SD 74.9 ± 8.5 74.4 ± 7.8 75.5 ± 9.2 .104
Education level
 Less than primary school 52 (7.9) 24 (6.6) 28 (9.6) .287
 Primary school 113 (17.3) 55 (15.2) 58 (19.8)
 Middle school 162 (24.7) 94 (26.0) 68 (23.2)
 High school 168 (25.6) 96 (26.5) 72 (24.6)
 College and above 160 (24.4) 93 (25.7) 67 (22.9)
Medical history
 Hypertension, n (%) 393 (60.0) 214 (59.1) 179 (61.1) .608
 Diabetes mellitus, n (%) 117 (17.9) 60 (16.6) 57 (19.5) .339
 Stroke, n (%) 117 (17.9) 64 (17.7) 53 (18.1) .892
 Heart disease, n (%) 253 (38.6) 136 (37.6) 117 (39.9) .537
Life habits
 Smoking, n (%) 77 (11.8) 41 (11.3) 36 (12.3) .704
 Drinking, n (%) 49 (7.5) 28 (7.7) 21 (7.2) .784
APOE ε4 positive, n (%) 115 (19.9) 63 (19.4) 52 (20.5) .759
MMSE, mean ± SD 26.4 ± 2.9 26.7 ± 2.8 26.1 ± 3.0 .009
MCI type
 aMCI-SD, n (%) 272 (41.5) 156 (43.1) 116 (39.6) .422
 aMCI-MD, n (%) 165 (25.2) 82 (22.7) 83 (28.3)
 naMCI-SD, n (%) 159 (24.3) 91 (25.1) 68 (23.2)
 naMCI-MD, n (%) 59 (9.0) 33 (9.1) 26 (8.9)

Abbreviations: MCI, mild cognitive impairment; aMCI-SD, amnestic mild cognitive impairment single domain; aMCI-MD, amnestic mild cognitive impairment multiple domains; naMCI-SD, non-amnestic mild cognitive impairment single domain; naMCI-MD, non-amnestic mild cognitive impairment multiple domains; MMSE, mini-mental state examination; APOE, apolipoprotein.

115/578.

63/324.

52/254.